Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
Abstract Background The disclosure in the media of a benefit with the use of dexamethasone in patients with COVID-19 infection sets precedents for self-medication and inappropriate use of corticosteroids. Methods This is a critical interpretive synthesis of the data available in the literature on th...
Main Authors: | Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13098-020-00583-7 |
Similar Items
-
Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
by: Vasiliki Romanou, et al.
Published: (2021-06-01) -
Dexamethasone in severe COVID-19 infection: A case series
by: Mohamed Eliwa Hassan, et al.
Published: (2020-01-01) -
The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01) -
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
by: Amber J. Giles, et al.
Published: (2018-06-01) -
The effect of dexamethasone on labor induction: a systematic review
by: Zaynab Mohaghegh, et al.
Published: (2021-08-01)